Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02318732 · ClinicalTrials.gov registry record · NA

Evaluation of California's Armed and Prohibited Persons System

A NA study of Violence, sponsored by University of California, Davis.

Active
Registry status
NA
Development phase
20,000
Enrollment target
1
Study location

NCT02318732 is a NA study of Violence that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 20,000 participants, above the 3,485-participant average among 19 other Violence trials with a reported enrollment target (474% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02318732, a NA study of Violence, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20,000 participants
Enrollment target
1
Study location

Study Summary

This study evaluates exposure to California's Armed and Prohibited Persons System (APPS) and risk of future violence and other important outcome events among individuals who legally purchased firearms in the past but have since become prohibited from owning them. The main hypothesis is that APPS will be associated with a significant reduction in risk for future violence among individuals who are directly affected.

Conditions Studied

Interventions

  • BEHAVIORAL APPS intervention

Study Locations (1)

California

  • UC Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 20,000 participants
Start Date 2015-02
Est. Completion 2026-06-21
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02318732

The ClinicalTrials.gov registry entry for NCT02318732 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,485-participant average among 19 other Violence trials with a reported enrollment target (474% higher). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Violence appearing as the primary indexed condition, and to 1 intervention - of which APPS intervention is the first listed.

NCT02318732 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02318732 about?

NCT02318732 is a clinical study titled "Evaluation of California's Armed and Prohibited Persons System". This study evaluates exposure to California's Armed and Prohibited Persons System (APPS) and risk of future violence and other important outcome events among individuals who legally purchased firearms in the past but have since become prohibited from owning them. The main hypothesis is that APPS wil...

What is the current status of trial NCT02318732?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20,000 participants. The study started on 2015-02. Estimated completion is 2026-06-21.

What conditions does trial NCT02318732 study?

This clinical trial studies the following conditions: Violence.

What interventions are being tested in trial NCT02318732?

The interventions under investigation include: APPS intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02318732?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02318732 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.